Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
基本信息
- 批准号:9027921
- 负责人:
- 金额:$ 31.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-15 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Promyelocytic LeukemiaAddressAntiviral AgentsAntiviral ResponseAntiviral TherapyBeliefBindingBiochemistryBiological AssayCell NucleusCellsCytomegalovirusCytomegalovirus InfectionsCytoplasmDNADNA VirusesDevelopmentDrug DesignDrug TargetingEndoplasmic ReticulumEquilibriumEventFluorescent in Situ HybridizationHandHealthHerpesviridaeHerpesvirus 1HomoHumanHybridsImmuneImmune System DiseasesImmune responseImmune systemImmunityInfectionInterferonsLeadLifeLightMaintenanceMalignant NeoplasmsMammalian CellMediatingMethodsMicrobeMicroscopyMolecular BiologyMorbidity - disease rateNuclearNuclear ExportPathway interactionsPilot ProjectsPropertyProteinsProteomicsRNA VirusesRecruitment ActivityRegulationReplication OriginResearchRoleSeriesSignal TransductionStagingSystemTestingUbiquitinViral ProteinsVirusWorkadapter proteinbasecellular imagingcytokineinterdisciplinary approachmarenostrinmortalitynovelnovel therapeuticsoptogeneticspathogenpublic health relevancesensorsmall hairpin RNAtransmission processviral DNA
项目摘要
DESCRIPTION (provided by applicant): The ability of the mammalian immune system to recognize pathogenic DNA, such as DNA from viruses, is essential for the onset of intrinsic and innate immune responses. This recognition is accomplished by specialized cellular proteins called DNA sensors, which bind foreign DNA and elicit the secretion of cytokines to alert neighboring cells and inhibit the spread of infection. Until recently, the sensing of foreign DNA was thought to occur only in subcellular compartments normally devoid of DNA. However, this long-standing belief failed to explain how the cell detects nuclear-replicating DNA viruses. Our lab's recent characterization of the first identified nuclear DNA sensor, IFI16, has helped to firmly establish the concept of nuclear sensing. We demonstrated that IFI16 functions to sense herpesviruses, including the important pathogens, human cytomegalovirus (HCMV) and herpes simplex virus type 1 (HSV-1) (Li et al. PNAS 2012; Li et al. Cell Host Microbe 2013). The discovery that sensing can occur in the nucleus opens a new direction for research in immunity that will increase our understanding of how balanced immune responses work to maintain a healthy system and how their misregulation leads to immune disorders, cancers, and virus-induced morbidity and mortality. However, a fundamental question that has yet to be answered is how the immune signal is propagated from the nucleus. We found that, while IFI16 remains nuclear during the early stages of HCMV and HSV-1 infections, the IFI16-mediated induction of antiviral cytokines requires the endoplasmic reticulum adapter protein STING-a hub for DNA sensing pathways. The requirements for eliciting an immune response from the nucleus and the mechanism of immune signal propagation to the cytoplasm remain elusive. Our proposal will address these important questions. First, we will characterize the mechanism by which IFI16 rapidly co-localizes with viral DNA in the nucleus. We have discovered that IFI16 is recruited to promyelocytic leukemia (PML) nuclear bodies (NBs) following infection. PML-NBs have been implicated in antiviral response and shown to localize to origins of replication of herpesviruses. Using a multidisciplinary approach, we will test our hypothesis that PML-NBs function as interaction centers where IFI16 concentrates its binding of viral DNA, setting the stage for immune signal initiation. Second, we will use molecular biology, biochemistry, optogenetics, and live cell imaging to define the IFI16 properties required for initiating nuclear immune signals. We
hypothesize that signal initiation requires IFI16 oligomerization via its pyrin domain at PML-NBs. Third, we will determine how the nucleus-derived immune signal is transmitted to the cytoplasm. We discovered that IFI16 interacts with interferon-inducible IFIT proteins, which shuttle to the nucleus upon infection. We propose mechanistic studies to test our hypothesis that IFI16-dependent immune signaling is relayed by such interactions to the STING hub. Collectively, our results will characterize a newly discovered aspect of immunity, nuclear sensing, by defining the fundamental mechanisms required for immune signal propagation.
描述(由申请人提供):哺乳动物免疫系统识别病原性DNA(如病毒DNA)的能力对于内在和先天免疫应答的发生至关重要。这种识别是由称为DNA传感器的专门细胞蛋白质完成的,它们结合外源DNA并引发细胞因子的分泌,以警告邻近细胞并抑制感染的传播。直到最近,外来DNA的感应被认为只发生在通常缺乏DNA的亚细胞区室中。然而,这种长期存在的信念未能解释细胞如何检测核复制DNA病毒。我们实验室最近对第一个确定的核DNA传感器IFI 16的表征有助于牢固地建立核传感的概念。我们证明了IFI 16具有感测疱疹病毒的功能,包括重要的病原体,人巨细胞病毒(HCMV)和单纯疱疹病毒1型(HSV-1)(Li et al. PNAS 2012; Li et al. Cell Host Microbe 2013)。传感可以发生在细胞核中的发现为免疫研究开辟了一个新的方向,这将增加我们对平衡的免疫反应如何维持健康系统以及它们的失调如何导致免疫紊乱,癌症和病毒诱导的发病率和死亡率的理解。然而,一个尚未回答的基本问题是免疫信号如何从细胞核传播。我们发现,虽然IFI 16在HCMV和HSV-1感染的早期阶段保持核,但IFI 16介导的抗病毒细胞因子的诱导需要内质网适配器蛋白STING-DNA传感途径的枢纽。从细胞核引发免疫应答的要求和免疫信号传播到细胞质的机制仍然难以捉摸。我们的建议将解决这些重要问题。首先,我们将描述IFI 16在细胞核中与病毒DNA快速共定位的机制。我们已经发现IFI 16在感染后被募集到早幼粒细胞白血病(PML)核体(NB)。PML-NB与抗病毒反应有关,并被证明定位于疱疹病毒的复制起点。使用多学科的方法,我们将测试我们的假设,即PML-NBs作为相互作用中心,IFI 16集中其病毒DNA的结合,为免疫信号启动设置阶段。其次,我们将使用分子生物学,生物化学,光遗传学和活细胞成像来定义启动核免疫信号所需的IFI 16特性。我们
假设信号起始需要IFI 16通过PML-NB处的pyrin结构域进行寡聚化。第三,我们将确定核源性免疫信号如何传递到细胞质。我们发现IFI 16与干扰素诱导的IFIT蛋白相互作用,后者在感染后穿梭于细胞核。我们提出了机制研究来验证我们的假设,即IFI 16依赖性免疫信号通过这种相互作用传递到STING中心。总的来说,我们的研究结果将通过定义免疫信号传播所需的基本机制来表征免疫的一个新发现的方面,即核传感。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ileana M. Cristea其他文献
The protein composition of human adenovirus replication compartments
人腺病毒复制区室的蛋白质组成
- DOI:
10.1128/mbio.02144-24 - 发表时间:
2024-11-29 - 期刊:
- 影响因子:4.700
- 作者:
Paloma Hidalgo;Amada Torres;Pierre M. Jean Beltran;Gamaliel López-Leal;Luca D. Bertzbach;Thomas Dobner;S. J. Flint;Ileana M. Cristea;Ramón A. González - 通讯作者:
Ramón A. González
Fpa (YlaN) is an iron(II) binding protein that functions to relieve Fur-mediated repression of gene expression in emStaphylococcus aureus/em
Fpa(YlaN)是一种铁(II)结合蛋白,其作用是缓解金黄色葡萄球菌中 Fur 介导的基因表达抑制。
- DOI:
10.1128/mbio.02310-24 - 发表时间:
2024-10-09 - 期刊:
- 影响因子:4.700
- 作者:
Jeffrey M. Boyd;Kylie Ryan Kaler;Karla Esquilín-Lebrón;Ashley Pall;Courtney J. Campbell;Mary E. Foley;Gustavo Rios-Delgado;Emilee M. Mustor;Timothy G. Stephens;Hannah Bovermann;Todd M. Greco;Ileana M. Cristea;Valerie J. Carabetta;William N. Beavers;Debashish Bhattacharya;Eric P. Skaar;Lindsey N. Shaw;Timothy L. Stemmler - 通讯作者:
Timothy L. Stemmler
emIn vitro/em and emex vivo/em proteomics of emMycobacterium marinum/em biofilms and the development of biofilm-binding synthetic nanobodies
海分枝杆菌生物膜的体外和体内蛋白质组学以及生物膜结合合成纳米抗体的开发
- DOI:
10.1128/msystems.01073-22 - 发表时间:
2023-05-03 - 期刊:
- 影响因子:4.600
- 作者:
Milka Marjut Hammarén;Hanna Luukinen;Alina Sillanpää;Kim Remans;Karine Lapouge;Tânia Custódio;Christian Löw;Henna Myllymäki;Toni Montonen;Markus Seeger;Joseph Robertson;Tuula A. Nyman;Kirsi Savijoki;Mataleena Parikka;Ileana M. Cristea;Paul Cos - 通讯作者:
Paul Cos
A Primer on Proteomic Characterization of Intercellular Communication in a Virus Microenvironment
病毒微环境中细胞间通讯的蛋白质组学表征入门
- DOI:
10.1016/j.mcpro.2025.100913 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:5.500
- 作者:
James C. Kostas;Colter S. Brainard;Ileana M. Cristea - 通讯作者:
Ileana M. Cristea
Liquid–liquid phase separation in innate immunity
天然免疫中的液-液相分离
- DOI:
10.1016/j.it.2024.04.009 - 发表时间:
2024-06-01 - 期刊:
- 影响因子:13.900
- 作者:
Dawei Liu;Jinhang Yang;Ileana M. Cristea - 通讯作者:
Ileana M. Cristea
Ileana M. Cristea的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ileana M. Cristea', 18)}}的其他基金
Methods and Logic in Molecular Biology Training Program
分子生物学方法与逻辑培训计划
- 批准号:
10721701 - 财政年份:2023
- 资助金额:
$ 31.87万 - 项目类别:
Dynamic virus-driven remodeling of ER-mitochondria contacts
内质网-线粒体接触的动态病毒驱动重塑
- 批准号:
10707412 - 财政年份:2022
- 资助金额:
$ 31.87万 - 项目类别:
Dynamic virus-driven remodeling of ER-mitochondria contacts
内质网-线粒体接触的动态病毒驱动重塑
- 批准号:
10608035 - 财政年份:2022
- 资助金额:
$ 31.87万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
10266082 - 财政年份:2015
- 资助金额:
$ 31.87万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
9973554 - 财政年份:2015
- 资助金额:
$ 31.87万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
10456254 - 财政年份:2015
- 资助金额:
$ 31.87万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
10672215 - 财政年份:2015
- 资助金额:
$ 31.87万 - 项目类别:
Host Factors Required for Dengue and Yellow Fever Virus Amplification
登革热和黄热病病毒扩增所需的宿主因素
- 批准号:
8522155 - 财政年份:2012
- 资助金额:
$ 31.87万 - 项目类别:
Host Factors Required for Dengue and Yellow Fever Virus Amplification
登革热和黄热病病毒扩增所需的宿主因素
- 批准号:
8391158 - 财政年份:2012
- 资助金额:
$ 31.87万 - 项目类别:
Proteomic Tools to Uncover the Role of Chromatin Remodeling in HIV-1 Infection
揭示染色质重塑在 HIV-1 感染中作用的蛋白质组学工具
- 批准号:
8117154 - 财政年份:2008
- 资助金额:
$ 31.87万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.87万 - 项目类别:
Research Grant














{{item.name}}会员




